2024-09-09

MDBriefCase Launches ‘Application of Health Economics and Pharmacoeconomics 2024-2025’ to Advance Health Economic Evaluation in Saudi Arabia

Riyadh, Saudi Arabia – [November 4, 2024] – MDBriefCase, a leading provider of interactive accredited continuing medical education for healthcare professionals worldwide, is pleased to announce the launch of its innovative educational program, Application of Health Economics and Pharmacoeconomics 2024-2025 – KSA. The program aims to drive change and evolution in health economic evaluation throughout the Kingdom of Saudi Arabia (KSA) and enable healthcare professionals to identify, measure, value, and compare the costs and consequences of different public health interventions.

Application of Health Economics and Pharmaeconomics is a comprehensive program that includes a mix of in-person and virtual workshops and mentorship opportunities. Given the increasing burden of diseases, the complexity of health technology, and progressive inflation in healthcare, this program addresses the critical need for high-quality patient care while maintaining budgetary control.

Professor David Strain, program faculty member said, “At a time when the complexity of health technology and the financial pressures on healthcare systems are at an all-time high, this program is invaluable in enabling healthcare practitioners to make informed, cost-effective decisions that enhance patient outcomes. I am thrilled to be a part of such a forward-thinking and impactful program.”

Prof. Ahmed Aljedai, Assistant Deputy Minister of Therapeutic Affairs for Support Services, Ministry of Health, said, “This comprehensive educational initiative addresses the critical need for informed decision-making in healthcare. By fostering a deeper understanding of value-based care, we can improve patient outcomes and ensure the sustainability of our healthcare system.”

By offering a flexible learning format, MDBriefCase ensures that participants in the program will receive education tailored to the modern demands of healthcare. The program has limited enrollment and is by invitation only.

Participants in the Application of Health Economics and Pharmaeconomics program will develop an awareness and understanding of the future direction of health economics in supporting sustainable healthcare delivery. They will also be equipped to adopt hands-on learning techniques through learn-engage, coach-refine, and empower-implement strategies.

The program launched on July 26th with the Steering Committee, during which key stakeholders identified and solidified the program’s objectives and its intended impact for the delegates and the region.

The second phase of the program, an exclusive event in November will bring together local and international industry leaders for an intensive two-day deep dive into the critical pillars of modern healthcare: Health Technology Assessment (HTA), Health Economics and Outcomes Research (HEOR), and Value-Based Healthcare (VBHC). 

Through a combination of expert-led lectures and immersive hands-on workshops, participants will gain a profound understanding of these essential frameworks, equipping them with the skills and insights to navigate and shape the future of healthcare systems. This is an unparalleled opportunity to engage with cutting-edge strategies that are redefining value in healthcare.

Partners and Endorsements

The program is supported by 

  • Amgen
  • Bayer
  • Boehringer Ingelheim
  • Exeter University, UK
  • Roche

Chairs

  • Prof. Ahmed Aljedai, Pharm.D, BCPS, FCCP, FAST, FASHP, Assistant Deputy Minister of Therapeutic Affairs for Support Services, Ministry of Health, Riyadh, Saudi Arabia.
  • Dr. Hajer Al-Mudaiheem, Pharm.D, MSc, Clinical Pharmacy, Director of Drug Policy and Regulation at the Deputyship of Therapeutic Affairs, Ministry of Health, Riyadh, Saudi Arabia.

International Expert Moderator Faculty

  • Dr. Tomasz Kluszczynski, PhD
  • Dr. Mouna Jameleddine, PharmD, MSc

International Experts Faculty

  • Prof. David Strain, MB, ChB, BSc (Hons) MD, FRCP
  • Prof. Marc Evans, MB, Bch, FRCP (UK), MD (Wales)

For more information and to learn about sponsorship opportunities, contact Mohammed Rish, Senior Director of Strategic Partnerships, MDBriefCase at maburish@mdbriefcase.com or Janet Kimura, Managing Director & EVP, Clinical Content and Education, Think Research at janet.kimura@mdbriefcase.com

About MDBriefCase 

MDBriefCase provides accredited continuing medical education for healthcare professionals across the Middle East. Our mission is to deliver high-quality, accessible education that encourages evidence-based behavioural change and improved quality measures, patient care and treatment outcomes.

Platinum Sponsors

Amgen Blue Logo bayer-logo

Author Agreement

In submitting your work (the “Work”) for potential posting on the MDBriefCase Healthcare Leadership Academy website (the “Website”), you (“You”) expressly agree to the following:

Review: MDBriefCase is pleased to consider the publication of Your Work on the Website.   The suitability of the Work for posting shall be determined by MDBRiefCase at its sole discretion. Nothing herein shall obligate MDBriefcase to post or otherwise publish the Work, or the maintain its posting in future.   

Editing; Identification: MDBriefcase shall have the right to edit the Work to conform to our standards of style, technological requirements, language usage, grammar and punctuation, provided that the meaning of the Work is not materially altered.  If posted, You will be identified as the author of the Work, or co-author if applicable.  

Grant of Rights:  As a condition of publication and for no monetary compensation, You hereby grant to MDBriefCase the following rights to the Work in any and all media whether now existing or hereafter developed, including print and electronic/digital formats:  (1) the exclusive right of first publication worldwide;  (2) the perpetual non-exclusive worldwide right to publish, reproduce, distribute, sell, adapt, perform, display, sublicense, and create derivative works, alone or in conjunction with other materials; (3) the perpetual non-exclusive worldwide right to use the Work, or any part thereof, in any other publication produced by MDBriefCase and/or on MDBriefCase’s website; and (4) the perpetual non-exclusive worldwide right to use the Work to promote and publicize MDBriefCase or its publications.  The grant of rights survives termination or expiration of this Agreement.    

Warranty:  You warrant that the Work is original with You and that it is not subject to any third party copyright; that You have authority to grant the rights in this Agreement; that publication of the Work will not libel anyone or infringe on or invade the rights of others; that You have full power and authority to enter into this Agreement; that the Work has not been published elsewhere in whole or in part; and that You have obtained permission from the copyright owner consistent with this Agreement for any third party copyrighted material in the Work.  This warranty survives termination or expiration of this Agreement.

Submission Agreement

Thank you for your interest in writing an article for the MDBriefCase Healthcare Leadership Academy website.

Audience and Appropriate Topics

The  Healthcare Leadership Academy welcomes submissions on all topics relevant to leaders in healthcare. Our topics include Leading in Healthcare, Leadership Lessons from COVID-19 and others. We prioritize stories that provide leadership advice to executives and managers in healthcare companies, offer actionable strategies for executing successful projects, and provide interesting angles on current healthcare topics. Submissions must be original work of the authors and unpublished.  When submitting, authors represent that they have included no material that is in violation of the rights of any other person or entity.

Parameters

Articles must be educational and non-promotional. If they mention the author’s company or any of the company’s products or services by name within the text, such mention should be very limited and used for reference only, not for promotion. (For example, an author might cite a survey conducted by his company but not describe his company’s product as a solution to a business problem.) Articles will be edited for clarity, style and brevity. The final headline is determined by the editor.

Length of Submissions

Guest articles for the MDBriefCase Healthcare Leadership Academy may run between 500 and 1000 words. 

Review

MDBriefCase reserves the right to accept or reject any submission  and the right to condition acceptance upon revision of material to conform to its criteria.   

No Compensation

There is no payment for contributed articles. However, MDBriefCase will give the author a byline. Authors are invited to link to the article on personal  websites, corporate websites and social media platforms.

Author Agreements

Each author understands and agrees that any submission accepted for posting is provided subject to MDBriefCase’s Author Agreement